# Acupuncture Therapy for COVID-Related Olfactory Loss

> **NCT04952389** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 30 (actual)

## Conditions studied

- Olfactory Dysfunction
- COVID-19

## Interventions

- **DEVICE:** Acupuncture Therapy
- **DRUG:** Budesonide
- **OTHER:** Olfactory Training

## Key facts

- **NCT ID:** NCT04952389
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-07
- **Primary completion:** 2023-04-21
- **Final completion:** 2023-06-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04952389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04952389, "Acupuncture Therapy for COVID-Related Olfactory Loss". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04952389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*